A comprehensive study on genome-wide coexpression network of KHDRBS1/Sam68 reveals its cancer and patient-specific association

Scientific Reports
B SumithraAsim Bikas Das

Abstract

Human KHDRBS1/Sam68 is an oncogenic splicing factor involved in signal transduction and pre-mRNA splicing. We explored the molecular mechanism of KHDRBS1 to be a prognostic marker in four different cancers. Within specific cancer, including kidney renal papillary cell carcinoma (KIRP), lung adenocarcinoma (LUAD), acute myeloid leukemia (LAML), and ovarian cancer (OV), KHDRBS1 expression is heterogeneous and patient specific. In KIRP and LUAD, higher expression of KHDRBS1 affects the patient survival, but not in LAML and OV. Genome-wide coexpression analysis reveals genes and transcripts which are coexpressed with KHDRBS1 in KIRP and LUAD, form the functional modules which are majorly involved in cancer-specific events. However, in case of LAML and OV, such modules are absent. Irrespective of the higher expression of KHDRBS1, the significant divergence of its biological roles and prognostic value is due to its cancer-specific interaction partners and correlation networks. We conclude that rewiring of KHDRBS1 interactions in cancer is directly associated with patient prognosis.

References

Dec 6, 1996·Science·C J Sherr
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M B EisenD Botstein
Dec 11, 1999·Nucleic Acids Research·I XenariosD Eisenberg
Mar 26, 2002·FEBS Letters·Andreas ZanzoniGianni Cesareni
Dec 13, 2002·Nature·Nathalie MatterHarald König
Jan 2, 2003·Nature Reviews. Cancer·Julian Downward
Jan 10, 2003·Nucleic Acids Research·Gary D BaderChristopher W V Hogue
Jan 15, 2003·BMC Bioinformatics·Gary D Bader, Christopher W V Hogue
Dec 19, 2003·Nucleic Acids Research·Suraj PeriAkhilesh Pandey
Oct 8, 2004·Critical Care : the Official Journal of the Critical Care Forum·Viv BewickJonathan Ball
Dec 3, 2004·Genes & Development·Paloma H GiangrandeJoseph R Nevins
Dec 25, 2004·Cellular and Molecular Life Sciences : CMLS·S NajibV Sánchez-Margalet
Dec 31, 2005·Nucleic Acids Research·Chris StarkMike Tyers
Mar 9, 2007·Bioinformatics·James Z WangChin-Fu Chen
Mar 21, 2007·The Journal of Cell Biology·Maria Paola ParonettoClaudio Sette
Oct 3, 2007·Genes, Chromosomes & Cancer·Derek L StirewaltJerald P Radich
Jan 15, 2008·Trends in Genetics : TIG·Talila VolkHila Toledano-Katchalski
Oct 1, 2008·BMC Bioinformatics·Sabry RazickIan M Donaldson
Sep 17, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Zhiling ZhangLibing Song
Aug 31, 2010·Nucleic Acids Research·Kai WangJinze Liu
Apr 5, 2011·Cell·Alan AshworthJorge S Reis-Filho
Jun 28, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Z LiL-B Song
Mar 7, 2012·Oncogene·T V Kalvik, T Arnesen
Jul 13, 2013·Nature·Debashish RayTimothy R Hughes
Sep 28, 2013·Nature Genetics·UNKNOWN Cancer Genome Atlas Research NetworkJoshua M Stuart
Feb 14, 2014·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Z ZhangZ Jiang
Dec 6, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mariya S LiyasovaStanley Lipkowitz
May 7, 2015·BMC Cancer·Zhiling ZhangFangjian Zhou
Jun 8, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yayun WangRunzhou Ni
Aug 15, 2015·BioMed Research International·Paola FrisoneMaria Paola Paronetto
Dec 15, 2015·Cell Host & Microbe·Shashank TripathiSumit K Chanda
Nov 30, 2016·Nature Methods·Dénes TüreiJulio Saez-Rodriguez
Jan 31, 2017·Nature Reviews. Cancer·Jacob-Sebastian Seeler, Anne Dejean
Oct 13, 2017·Open Biology·Yanfang YangShufang Liang
Nov 1, 2017·Molecular and Cellular Biology·Venkatesh KotaTilman Heise
Dec 5, 2017·Cell Systems·Maximilian BillmannMichael Boutros
Jan 28, 2016·Signal Transduction and Targeted Therapy·Yong Peng, Carlo M Croce
Mar 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Z LiL-B Song

❮ Previous
Next ❯

Citations

Feb 4, 2021·OncoTargets and Therapy·Vennela Tulluri, Venkatesh V Nemmara

❮ Previous
Next ❯

Methods Mentioned

BETA
two-hybrid
pull down

Software Mentioned

LAML
BioGrid
Metascape
IM
OmniPath
InWeb
R
GraphPad Prism
Hmisc Package in

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.